Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

Clinical trials have shown the benefits of acetylcholinesterase inhibitors, such as donepezil and galantamine, and an N-methyl-D-aspartate receptor antagonist, memantine, in patients with Alzheimer’s disease (AD). However, little is known regarding the effects of switching from donepezil 5 mg/day to...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Kano, Osamu, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Iwamoto, Konosuke, Nagaoka, Tetsuro, Hirayama, Takehisa, Miura, Ken, Nagata, Riya, Kiyozuka, Tetsuhito, Aoyagi, Jo, Sato, Ryuta, Eguchi, Teruo, Ikeda, Ken, Iwasaki, Yasuo
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2013
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575212/
https://ncbi.nlm.nih.gov/pubmed/23431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S40682
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍